Clinical Trials
4
Active:0
Completed:0
Trial Phases
2 Phases
Phase 1:2
Phase 3:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (50.0%)Phase 3
2 (50.0%)Evaluation of the Pharmacodynamics of a Heparin With Its Biological Comparator, Subcutaneous Administration
Phase 1
Not yet recruiting
- Conditions
- Anticoagulant
- First Posted Date
- 2023-03-29
- Last Posted Date
- 2023-03-29
- Lead Sponsor
- Blau Farmaceutica S.A.
- Target Recruit Count
- 68
- Registration Number
- NCT05788913
Effectiveness and Safety Study of Filgrastine® in Patientes With Breast Cancer Treated With Myelotoxic Chemotherapy
Phase 3
Not yet recruiting
- Conditions
- Breast Cancer
- First Posted Date
- 2023-03-29
- Last Posted Date
- 2023-03-29
- Lead Sponsor
- Blau Farmaceutica S.A.
- Target Recruit Count
- 60
- Registration Number
- NCT05790096
Evaluation of the Pharmacodynamics of a Heparin With Its Biological Comparator, Intravenous Administration
Phase 1
Not yet recruiting
- Conditions
- Anticoagulant
- First Posted Date
- 2023-03-29
- Last Posted Date
- 2023-03-29
- Lead Sponsor
- Blau Farmaceutica S.A.
- Target Recruit Count
- 68
- Registration Number
- NCT05788900
Asses the Impact of Early Starting Erythropoetin in the Reduction of Transfusions Blood in Childrens
Phase 3
Not yet recruiting
- Conditions
- Chemotherapeutic-Induced AnemiaAnemiaNeoplasms
- First Posted Date
- 2023-01-30
- Last Posted Date
- 2023-01-30
- Lead Sponsor
- Blau Farmaceutica S.A.
- Target Recruit Count
- 320
- Registration Number
- NCT05704894
News
No news found